A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy.

Affiliation auteurs!!!! Error affiliation !!!!
TitreA randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy.
Type de publicationJournal Article
Year of Publication2016
AuteursFizazi K, Ulys A, Sengelov L, Moe M, Ladoire S, Thiery-Vuillemin A, Flechon A, Sabbatini R, Bellmunt J, Climent MAngel, Chowdhury S, Dumez H, Matouskova M, Penel N, Liutkauskiene S, Stachurski L, Sternberg CN, Baton F, Germann N, Daugaard G
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedJAN 10
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2016.34.2_suppl.201